BioTech Revolution Certificate
Even though there’s no gene for fate yet, one day there could be. A new breed of biotechnology companies is harnessing cellular and biomolecular processes and developing technologies and products to fight disease. Invest in the next cure with our selection of firms exceeding the US $1 billion market cap.
BioTech Revolution
ISIN: CH0341837877
The pharmaceutical industry is going through a minor revolution. Biotechnology has a broad mandate, covering a wide range of processes for transforming living organisms for human purposes. New companies in the sector exploit cellular and bio-molecular processes to develop technologies and products to fight disease. With public and private investors and big pharma all expecting the next big breakthrough to come from this dynamic sector, valuations are on the rise. We built this certificate by filtering on firms with a market capitalisation of over $1 billion and positive sales growth over the past two years, ensuring that they have sufficient cash flow to fund the next blockbuster.
Benefits
Increased growth potential
Broad diversification
Professionally and actively managed
Traded on the SIX Swiss Exchange
USD 9.- flat transaction costs (excluding stock exchange and real time fees)
Start trading now
Want to get ahead of the curve?
Subscribe to our Newsletter to receive market news, trade ideas & new themes